- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05726877
Optimal PEEP in Pediatric Patients Under 17 Years of Age.
February 3, 2023 updated by: Seoul National University Hospital
Determination of Optimal Positive End-expiratory Pressure in Prone Position During General Anesthesia Using Electrical Impedance Tomography in Pediatric Patient Under 17 Years of Age
This study aimed to investigate the differences in positive end-expiratory pressure titration in the supine and prone positions by age in pediatric patients under 17 years of age who received general anesthesia and then evaluate the hemodynamic stability.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
51
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hee-Soo Kim, M.D., Ph.D.
- Phone Number: 02-2072-3664
- Email: dami0605@snu.ac.kr
Study Locations
-
-
-
Seoul, Korea, Republic of
- Recruiting
- Seoul National University Hospital
-
Contact:
- Hee-Soo Kim, M.D.,Ph.D.
- Phone Number: 02-2072-3664
- Email: dami0605@snu.ac.kr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 second to 16 years (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients who are scheduled to undergo general anesthesia in the prone position
- patients who are in age under 17 years
Exclusion Criteria:
- had cyanosis or chronic respiratory failure
- had respiratory distress syndrome or bronchopulmonary dysplasia
- had laryngotracheal diseases
- had pulmonary hypertension
- receiving oxygen therapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Experimental arm
All patients will be enrolled in the same arm.
|
Titrating positive end-expiratory pressure
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Optimal positive end-expiratory pressure (PEEP)
Time Frame: 10 minutes after intubation
|
result of decremental PEEP trial
|
10 minutes after intubation
|
|
Optimal positive end-expiratory pressure (PEEP)
Time Frame: 60 minutes after prone positioning
|
result of decremental PEEP trial
|
60 minutes after prone positioning
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Impedance tidal variation
Time Frame: 10 minutes after intubation
|
respiratory parameters measured by Electrical Impedance Tomography (EIT) device
|
10 minutes after intubation
|
|
Impedance tidal variation
Time Frame: 60 minutes after prone positioning
|
respiratory parameters measured by EIT device
|
60 minutes after prone positioning
|
|
regional respiratory system compliance
Time Frame: 60 minutes after prone positioning
|
respiratory parameters measured by EIT device
|
60 minutes after prone positioning
|
|
regional respiratory system compliance
Time Frame: 10 minutes after intubation
|
respiratory parameters measured by EIT device
|
10 minutes after intubation
|
|
overdistension or atelectasis
Time Frame: 10 minutes after intubation
|
respiratory parameters measured by EIT device
|
10 minutes after intubation
|
|
overdistension or atelectasis
Time Frame: 60 minutes after prone positioning
|
respiratory parameters measured by EIT device
|
60 minutes after prone positioning
|
|
end-expiratory lung volume
Time Frame: 10 minutes after intubation
|
respiratory parameters measured by EIT device
|
10 minutes after intubation
|
|
end-expiratory lung volume
Time Frame: 60 minutes after prone positioning
|
respiratory parameters measured by EIT device
|
60 minutes after prone positioning
|
|
end-expiratory lung impedance
Time Frame: 10 minutes after intubation
|
respiratory parameters measured by EIT device
|
10 minutes after intubation
|
|
end-expiratory lung impedance
Time Frame: 60 minutes after prone positioning
|
respiratory parameters measured by EIT device
|
60 minutes after prone positioning
|
|
regional ventilation delay
Time Frame: 10 minutes after intubation
|
respiratory parameters measured by EIT device
|
10 minutes after intubation
|
|
regional ventilation delay
Time Frame: 60 minutes after prone positioning
|
respiratory parameters measured by EIT device
|
60 minutes after prone positioning
|
|
center of ventilation
Time Frame: 10 minutes after intubation
|
respiratory parameters measured by EIT device
|
10 minutes after intubation
|
|
center of ventilation
Time Frame: 60 minutes after prone positioning
|
respiratory parameters measured by EIT device
|
60 minutes after prone positioning
|
|
vital signs
Time Frame: 10 minutes after intubation
|
blood pressure (mmHg)
|
10 minutes after intubation
|
|
vital signs
Time Frame: 60 minutes after prone positioning
|
blood pressure (mmHg)
|
60 minutes after prone positioning
|
|
vital signs
Time Frame: 10 minutes after intubation
|
oxygen saturation (%)
|
10 minutes after intubation
|
|
vital signs
Time Frame: 60 minutes after prone positioning
|
oxygen saturation (%)
|
60 minutes after prone positioning
|
|
vital signs
Time Frame: 10 minutes after intubation
|
heart rate (BPM)
|
10 minutes after intubation
|
|
vital signs
Time Frame: 60 minutes after prone positioning
|
heart rate (BPM)
|
60 minutes after prone positioning
|
|
arterial blood gas analysis, if patients has arterial catheter
Time Frame: 10 minutes after intubation & 60 minutes after prone positioning
|
oxygen and cardon dioxide tension
|
10 minutes after intubation & 60 minutes after prone positioning
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Hee-Soo Kim, MD.Ph.D., Professor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
October 17, 2022
Primary Completion (ANTICIPATED)
December 31, 2023
Study Completion (ANTICIPATED)
August 31, 2024
Study Registration Dates
First Submitted
January 6, 2023
First Submitted That Met QC Criteria
February 3, 2023
First Posted (ESTIMATE)
February 14, 2023
Study Record Updates
Last Update Posted (ESTIMATE)
February 14, 2023
Last Update Submitted That Met QC Criteria
February 3, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 2208-091-1351
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.